SynthesisResearch and practice in thrombosis and haemostasis2026
Circadian clock regulation of hemostasis: a systematic review of molecular pathways.
Synthesis in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Biological clocks and blood clots in space: circadian disruption-induced modulation of thrombosis risk.Research and practice in thrombosis and haemostasis · 2026Pooled it
- Timing the clot: circadian rhythms in hemostasis.Research and practice in thrombosis and haemostasis · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thrombotic events such as myocardial infarction and stroke exhibit circadian variation with early-morning peaks, implicating intrinsic biological regulation, yet the molecular mechanisms coordinating hemostatic function remain unclear. This systematic review synthesizes evidence linking circadian rhythms and clock genes to hemostatic regulation and highlights the underlying molecular pathways. A comprehensive literature search of PubMed, Scopus, and Web of Science was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Human and animal studies evaluating circadian rhythm, circadian clock genes, or clock-modulating interventions in relation to platelet function, coagulation, fibrinolysis, or thrombosis were included. Of the 1048 articles screened at the level of title and abstract independently by 2 authors, 26 studies met the inclusion criteria and were categorized into 4 major thematic domains of circadian hemostatic regulation as follows: (1) circadian orchestration of hemostasis across populations and experimental models; (2) genetic and pharmacologic modulation of circadian clock components; (3) circadian gene expression in platelets and megakaryocytes; and (4) environmental and lifestyle influences on circadian hemostatic coordination. Collectively, the evidence demonstrates that circadian clocks function as active regulators of thrombotic homeostasis. Core clock components, particularly
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.